Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Payables (2017 - 2021)

Historic Payables for Cogent Biosciences (COGT) over the last 5 years, with Q3 2021 value amounting to $4.3 million.

  • Cogent Biosciences' Payables rose 58059.47% to $4.3 million in Q3 2021 from the same period last year, while for Sep 2021 it was $4.3 million, marking a year-over-year increase of 58059.47%. This contributed to the annual value of $732000.0 for FY2020, which is 7700.28% down from last year.
  • According to the latest figures from Q3 2021, Cogent Biosciences' Payables is $4.3 million, which was up 58059.47% from $2.0 million recorded in Q2 2021.
  • Cogent Biosciences' 5-year Payables high stood at $5.5 million for Q3 2018, and its period low was $315000.0 during Q1 2021.
  • For the 5-year period, Cogent Biosciences' Payables averaged around $2.0 million, with its median value being $1.6 million (2019).
  • In the last 5 years, Cogent Biosciences' Payables plummeted by 7700.28% in 2020 and then surged by 58059.47% in 2021.
  • Cogent Biosciences' Payables (Quarter) stood at $1.3 million in 2017, then increased by 12.85% to $1.5 million in 2018, then surged by 109.55% to $3.2 million in 2019, then crashed by 77.0% to $732000.0 in 2020, then surged by 494.13% to $4.3 million in 2021.
  • Its last three reported values are $4.3 million in Q3 2021, $2.0 million for Q2 2021, and $315000.0 during Q1 2021.